Landscapes / Companies
Zydus Therapeutics Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
6 active
17 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in other | 18 Apr 2027Phase 3 trial completes | |||
| Next date | 18 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Primary Biliary Cholangitis, Cholestatic Liver Disease and 2 more | ||||
| Open drug page | |||||
— |
Zydus Lifesciences Limited |
Phase 2 | Mar 2028Phase 2 trial completes | ||
| Next date | Mar 2028 · Phase 2 trial completes | ||||
| Also tested for | Amyotrophic Lateral Sclerosis (ALS) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021